Concepedia

Martin Gunnarsson

MG

39

Publications

3.2K

Citations

21

H-Index

1998

Active since

Affiliations

Örebro University(Current)

Umeå University

Karolinska Institutet

Linköping University

University of Gothenburg

Martin Gunnarsson is an author at Örebro University specializing in medicine, multiple sclerosis, and clinical trials.

Top concepts

Publications per year

1998–2025

39

Publications

39

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 492 citations · Full text

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Lenka Novakova, Henrik Zetterberg, Peter Sundström et al. · Neurology · 2017 · 409 citations · Full text

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Martin Gunnarsson, Clas Malmeström, Markus Axelsson et al. · Annals of Neurology · 2010 · 337 citations · Full text

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

, , +8

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

Niklas Norgren, Peter Sundström, Anders Svenningsson et al. · Neurology · 2004 · 241 citations

Rows per page

1–5 of 39